Titration modifications were permitted across the SURMOUNT trials, and GI discontinuation rates remained below 5% in all dose arms when investigators used flexible scheduling
Our programs are designed to empower patients by addressing underlying factors contributing to weight gain, resulting in transformative and lasting changes
However, no AEs were observed in the severe renal impairment group, in which the two patients with T2D were also taking stable concomitant antidiabetic medication
Clinical studies in PCOS populations show variable individual responses, with research demonstrating improvements in weight, metabolic parameters, and PCOS symptoms when combined with lifestyle modifications
Zepbound comes as a vial, a KwikPen, or a single-dose pen
It is not linked, so the original paper is worth checking directly